Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-06
1995-10-24
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 4900, A61K 3144
Patent
active
054608198
ABSTRACT:
Methods are disclosed for treating PQQ-responsive heavy metal toxicity which include the administration of PQQ to a patient in need thereof. The toxicity may be associated with such heavy metals as lead, indium and vanadium.
REFERENCES:
patent: 4898870 (1990-02-01), Narutomi et al.
patent: 5061711 (1991-10-01), Urakami et al.
patent: 5075116 (1991-12-01), LaHaye et al.
patent: 5145862 (1992-09-01), Aizenman et al.
Gallop et al., "Is the Antioxidant, Anti-Inflammatory Putative New Vitamin, PQQ, Involved with Nitric Oxide in Bone Metabolism?" Abstracts, Connective Tissue Research, #9215015, vol. 27, 1992.
Gallop et al., "Quinone Cofactors In, On and Out of Proteins: Superoxide Removal with Hydrogen Salvaging." (Abstract) Meeting of the Protein Society, 1991.
Fluckiger et al. "First Isolation of Methoxatin (PQQ) from Bovine Skim Milk and Other Mamalian Sources." (Abstract) FASEB, Spring Meeting, 1991.
Gallop et al., "Cofactor PQQ in Red Cells, Neutrophils and Biological Fluids, Catalyzes . . . ", (Abstract V-4) Internat'l Symposium on PQQ and Quinoproteins, Nov. 19-22, 1991, Yamaguchi, JP.
Gibbons, "Vitamin or Just Vital?" Science News, vol. 139, p. 332, 1991.
Gomez et al., "Evaluation of the efficacy of various chelating agents on urinary excretion and tissue distribution of vanadium in rats," Toxicology Letters, vol. 57, pp. 227-234, 1991.
Klinman et al., "Status of the cofactor identity in copper oxidative enzymes," FEBS Letters, vol. 282, pp. 1-4, 1991.
McIntire et al., "A New Cofactor in a Prokaryotic Enzyme: Tryptophan Tryptophylquinone as the Redox . . . ", Science, vol. 252, pp. 817-823, 1991.
Nishigori et al., "Evaluation of Pharmacological Properties of PQQ," (Abstract V-3) 2nd International Symposium on PQQ and Quinoproteins, Nov. 19-22, 1991, Yamaguchi, JP.
Paz et al., "Specific Detection of Quinoproteins by Redox-cycling Staining," J. Biol. Chem., vol. 266, pp. 689-691, 1991.
Rucker et al., "Pyrroloquinoline Quinone: Effects of Dietary Deprivation on Growth, Connective Tissue . . . , " (Abstract V-2) 2nd International Symposium on PQQ and Quinoproteins, Nov. 19-22, 1991, Yamaguchi, JP.
Sato et al., "Oxyradical Scavenging Activities of PQQ and its Derivatives Against O.sub.2 and .OH," (Abstract PIII-2) International Symposium on PQQ and Quinoproteins, Nov. 19-22, 1991, Yamaguchi, JP.
Smidt, et al., "Does the Intestinal Microflora Synthesize Pyrroloquinoline Quinone?" BioFactors, vol. 3, pp. 53-59, 1991.
Smidt et al., "Intestinal Absorption and Tissue Distribution of [.sup.14 C] Pyrrolquinoline Quinone in Mice (43219," Proc. Soc. Exp. Bio. Med., vol. 197, pp. 27-31, 1991.
Suzuki et al., "Assay for PQQ in Mammalian Tissues by Gas Chromatography/Mass Spectrometry," (Abstract V-5) 2nd International Symposium on PQQ and Quinoproteins, Nov. 19-22, 1991, Yamaguchi, JP.
Tsuchida et al., "Protective Effect of Oxazolo Pyrroloquinoline (QPQ) Against Experimental Liver Injury," (Abstract V-6) 2nd International Symposium on PQQ and Quinoproteins, Nov. 19-22, 1991, Yamaguchi, JP.
"The Best News of the Year," Longevity, pp. 24,26, May, 1991.
Domingo et al., "Chelating agents in the treatment of acute vanadyl sulphate intoxication in mice," Toxicology, vol. 62, pp. 203-211, 1990.
Gallop et al., "The Biological Signficance of Quinonoid Compounds in, on, and out of Proteins . . . " Chemtracts-Biochemistry and Molecular Biology, 1:357-374, 1990.
Hamagishi et al., "New Biological Properties of Pyrroloquinoline Quinone and Its Related Compounds: . . . , " The Journal of Pharmacology and Experimental Therapeutics, vol. 255, pp. 980-985, 1990.
Janes et al., "A New Redox Cofactor in Eukaryotic Enzymes: 6-Hydroxydopa at the Active Site of Bovine . . . , " Science, vol. 248, pp. 981-987, 1990.
Kumazawa, et al., "Failure to Verify the Presence of Pyrroloquinoline Quinone (PQQ) in Bovine Plasma . . . , " Archives of Biochemistry and Biophysics, vol. 283, pp. 533-536, 1990.
Lawren, "A New Piece in the Aging Puzzle," Longevity, vol. 2, pp. 35-37, 1990.
Michaud-Soret et al., "Soybean Lipoxygenases-1, -2a, -2b, and -2c No Not Contain PQQ," Biochemical and Biophysical Research Communications, vol. 172, pp. 1122-1128, 1990.
Veldink et al., "Soybean Lipoxygenase -1 is not a quinoprotein," FEBS Letters, vol. 270, pp. 135-138, 1990.
Zychlinski et al., "Inhibitory Effects of Vanadium Pentoxide on Respiration of Rat Liver Mitochondria," Archives of Environmental Contamination and Toxicology, vol. 19, pp. 138-142, 1990.
Duine et al., "Quinoproteins, Enzymes with Pyrrolo-Quinoline Quinone as Cofactor," Annu. Rev. Biochem. 58:403-26, 1989.
Killgore et al., "Nutritional Importance of Pyrroloquinoline Quinone," Science, vol. 245, pp. 797-896, 1989.
Nishigori et al., "Preventive Effects of Pyrroloquinoline Quinone on Formation of Cataract and Decline . . . , " Life Sciences, vol. 45, pp. 593-598, 1989.
Richelmi et al., "Multiple Mechanisms of Vanadate-Induced Cell Killing," Biological Trace Element Research vol. 21, pp. 331-335, 1989.
Robertson et al., "Spectral Studies of Bovine Dopamine .beta.-Hydroxylase", The Journal of Biological Chemistry, vol. 264, pp. 19916-19921, 1989.
Buescher et al., "Antioxidant Properties of Human Colostrum," Pediatric Research, vol. 24, pp. 14-19, 1988.
Hobara et al., "Quinone Derivatives Lower Blood and Liver Acetaldehyde but Not Ethanol Concentrations . . . ," Pharmacology, 37:264-267, 1988.
Houck et al., "Biosynthesis of Pyrroloquinoline Quinone. 1. Identification of Biosynthetic Precursors . . . ," J. Am. Chem. Soc., vol. 110, pp. 6920-6921, 1988.
Paz et al., "Direct and Amplified Redox-Cycling Measurements of PQQ in Quinoproteins and . . . , " in Jongejan et al., eds. PQQ and Quinoproteins, Kluwer Acad. Pub. (Boston), pp. 131-143, 1989.
Watanabe et al., "Protective Effect of Pyrroloquinoline Quinone Against Experimental Liver Injury in Rats," Current Therapeutic Research, vol. 44, pp. 896-901, 1988.
Van Kleef et al., "L-Tyrosine is the precursor of PQQ biosynthesis in Hyphomicrobium X," FEBS, vol. 237, pp. 91-97, 1988.
Hansen et al., "Hemolytic Activity of Vanadylsulphate and Sodium Vanadate," Acta, vol. 59, pp. 562-565, Supplement VI, 1986.
Buchi et al., "A Synthesis of Methoxatin," J. Am. Chem. Soc., vol. 107, ppp. 5555-5556, 1985.
Nechay, "Mechanisms of Action of Vanadium," Ann. Rev. Pharmacol. Toxicol, 24:501-524, 1984.
Jones et al., "Chelate Antidotes for Sodium Vanadate and Vanadyl Sulfate Intoxication in Mice," Journal of Toxicology and Environmental Health, vol. 12, pp. 749-756, 1983.
Gainor et al., "Synthesis of the Bacterial Coenzyme Methoxatin," J. Org. Chem., vol. 47, pp. 2833-2837, 1982.
Vyskocil et al., The Lancet, pp. 1078-1079, May 8, 1982.
Jung et al., The Journal of Organic Chemistry, vol. 47, pp. 1148-1150, 1982.
Gainor et al., The Journal of Organic Chemistry, vol. 46, pp. 4317-4319, 1981.
Corey et al., Journal of the American Chemical Society, vol. 103, pp. 5599-5600, 1981.
Salisbury et al., Nature, vol. 280, pp. 843-844, 1979.
Gallop Paul M.
Paz Mercedes A.
Children's Medical Center Corporation
Henley III Raymond J.
LandOfFree
Method for treating PQQ-responsive heavy metal toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating PQQ-responsive heavy metal toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating PQQ-responsive heavy metal toxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1885035